Search
for
Sort by
Research 661–690 of 1000+
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Current Management and Treatment Options for Breast Pain
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- Experimental Confirmation of a Distinctive Diffraction Pattern in Hair From Women With Breast Cancer
- Tamoxifen-Induced Female Androgenetic Alopecia in a Patient with Breast Cancer
- Breast cancer resistance protein identifies clonogenic keratinocytes in human interfollicular epidermis
- Characterization of a Test for Invasive Breast Cancer Using X-ray Diffraction of Hair—Results of a Clinical Trial
- Breast Implant-Associated Immunological Disorders
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis
- Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
- Survey on adverse events associated with drug therapy for breast cancer patients
- Identification of Breast Cancer-Associated Lipids in Scalp Hair
- Breast Cancer: The Psychological Impact of Diagnosis, Treatment, and Remission
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)
- Breast Embryology, Anatomy, and Physiology
- Cutaneous polyarteritis nodosa presenting with digital gangrene and breast ulcer
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- EFFICACY AND SAFETY OF STANDARDIZED CINNAMON BARK EXTRACT FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED WEIGHT LOSS AND ALOPECIA IN PATIENTS WITH BREAST CANCER: A RANDOMIZED, DOUBLE-BLIND, AND PLACEBO-CONTROLLED STUDY
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Dermoscopy of neoplastic alopecia secondary to cutaneous metastasis from breast carcinoma
- Hair relaxer use and breast cancer risk by tumor molecular subtypes.
- Efficacy of Scalp Cooling combined with DHL-HisZnNa Lotion in the Prevention of Chemotherapy-Induced Alopecia in Patients with Breast Cancer
- Quality of Life in Slovak Breast Cancer Survivors: A Cross-Sectional Study Using EORTC QLQ-C30 and BR23
- Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) in a 56-Year-Old Patient With Silicone Breast Implants: A Case Report